About Presentation Governance & scientific and medical advice Science Approach Scientific publications Solutions Pipeline Valedia® Others products Investors Stock market data Financial Calendar Investor Relations Press releases Documentation News News Press Releases Contact in For a zero diabetes world VALBIOTIS is specialized in the development of innovative nutritional solutions dedicated to the prevention of cardio-metabolic diseases and to the nutritional support of patients. Learn more Valedia® A world first for 527 million pre-diabetics. After a positive clinical phase I / II, phase IIa is in progress. Three other studies will take place in Europe, the United States and Canada including more than 400 pre-diabetic subjects. Our product Valedia® News 14.06.2017 Bio Convention San Diego Lire plus 12.06.2017 77èmes sessions scientifiques de l’Association Américaine du Diabète (ADA) Lire plus Voir toutes les actualités Derniers tweets @Valbiotis Valbiotis Bâtiment 12F - ZI des 4 Chevaliers Rue Paul Vatine - 17180 Périgny - France LinkedIn Twitter © Valbiotis – Tous droits réservés Mentions légales – Création site web par Adveris